Home Search
infectious diseases - search results
If you're not happy with the results, please do another search
COVID-19 and Africa’s volatile changing epidemics landscape
Here, SACIDS Foundation for One Health discuss the volatile changing epidemics landscape in Africa.
COVID-19 survivors can donate plasma to vaccine testing
A study by the Bloomberg School of Public Health found that severe COVID-19 patients can produce strong antibodies for vaccine testing - especially the older male population.
New study finds 40% of plant species are at risk of extinction
A new study highlights that 40% of plant species are at threatened with extinction due to the continued destruction of our natural world.
How can Japan remain a world competitor in Science and Technology?
As many countries increase their participation in Science and Technology, Japan has noticed a decrease in their own. Here, we chart the priorities for the country to remain a world leader in science and technology policy.
The RSIF-PASET Programme: Food security and agribusiness at SACIDS Foundation
Here, Professor Gerald Misinzo and Professor Mark Rweyemamu discuss the potential of the RSIF-PASET Programme.
Sustainable agriculture in Japan
Open Access Government explores how Japan’s Ministry of Agriculture, Forestry and Fisheries is working towards sustainably reducing the environmental impact of agriculture and livestock.
How did COVID-19 spread to Europe and the U.S?
A new study combines genomics from COVID-19 samples with computer-simulated epidemics and travel records to reconstruct the virus' spread across the world.
COVID-19: New study highlights the importance of social distancing
A new study shows travelling from the home is associated with significantly higher likelihood of contracting COVID-19, while strict social distancing prevents infection.
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Vitamin D and immune tolerance in pregnancy and beyond
Drs Yuping Wang and David F. Lewis from Louisiana State University Health Sciences Center – Shreveport discuss the impact of vitamin D in regulating immune tolerance and foetal development in pregnancy.
Finding new antibiotics: The genome way
Professor Tilmann Weber discusses how microbial genomics helps to find the next generation of antibiotics in the race against antimicrobial resistance.
Matt Hancock announces end of Public Health England
Yesterday Matt Hancock announced the end of Public Health England (PHE), which will be absorbed into a new organisation.
Let’s get better prepared for the next health crisis in the EU!
Paul De Raeve, Secretary General and Elisabeth Adams, President of the European Federation of Nurses Associations state the case for being better prepared for the next health crisis in the European Union in light of COVID-19.
21 drugs that could help to treat COVID-19
A study recently identified 21 existing drugs that could improve the effect of remdesivir.
COVID-19 test can give wrong result when taken too early
Johns Hopkins researchers found taking the COVID-19 test too early can give the wrong result, making you falsely COVID-free.
NUH NHS Trust designs fully-electronic system to test staff for COVID-19
Nottingham University Hospitals NHS Trust (NUH) has designed, set-up and trialled a fully-electronic system to test staff for COVID-19.
Cytochromes P450: Chemistry for drugs, metabolism, and beyond
Joseph Najjar and Andrew K. Udit, PhD from the Department of Chemistry at Occidental College enlighten us on the importance of Cytochromes P450 in medicine and industry.
Obesity: The urgent need to tackle Britain’s weight problem
Tam Fry FRSA, Chairman of the National Obesity Forum provides his opinion on the urgent need to tackle Britain’s weight problem.
Enduring research: The constant threat of influenza virus outbreaks
Here, experts Stephan Pleschka, Oliver Planz and Stephan Ludwig walk us through the constant threat of influenza virus outbreaks and the benefit of enduring research in antiviral drug development.
Expert comment: Now is the time to prepare for the next pandemic
Professor Martin Michaelis and Dr Mark Wass, University of Kent, School of Biosiences, say it is crucial to overcome COVID-19 and to prepare for the next pandemic.